Molecular cytogenetics of pituitary adenomas, assessed by FISH technique

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 205-216

  Kontogeorgos, George ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; CHROMOSOME ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; HYPOPHYSIS TUMOR; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; REVIEW;

ADENOMA; CYTOGENETIC ANALYSIS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; PITUITARY NEOPLASMS;

EID: 4043083604     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000079046     Document Type: Article

References (47)

1. Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC: Delineation of individual human chromosomes in metaphase and interphase cells in situ suppression hybridization using recombinant DNA libraries. Hum Genet 1988;8:235-246.
2. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J: Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 1988;85:9138-9142.
3. Mitelman F, Johansson B, Mandhal N, Mertens F: Clinical signif icance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 1997;95:1-8.
4. Mark J, Dahlenfors R, Wedell B: Impact of in vitro technique used on the cytogenetic patterns in pleomorphic adenomas. Cancer Genet Cytogenet 1997;95:9-15.
5. Kiechle-Schwarz M, Decker HJ, Berger CS, Fiebig HH, Sandberg AA: Detection of monosomy in interphase nuclei and identification of marker chromosomes using biotinylated β-satellite DNA probes. Cancer Cell Genet Cytogenet 1991;51:23-33.
6. Meyne J, Moyzis RK: In situ hybridization protocols; in Choo KHA (ed): Methods in Molecular Biology. Totowa, Humana, 1994, vol 33, pp 63-74.
7. Kontogeorgos G, Kovacs K: FISHing chromosomes in endocrinology. Endocrine 1997;5:235-240.
8. Kontogeorgos G: The art and applications of FISHing in endocrine pathology. Endocr Pathol 2000;11:123-136.
9. Kontogeorgos G, Kapranos N, Thodou E: Applications of FISH in pathology; in Lloyd RV (ed):Morphologic Methods. Totowa, Humana Press, 2001, pp 91-111.
10. Kontogeorgos G, Kapranos N, Kokka E, Orphanidis G, Rologis D: Molecular cytogenetics of chromosome 11 in pituitary adenomas: A comparison of fluorescence in situ hybridization and DNA ploidy study. Hum Pathol 1999;30:1377-1382.
11. Kapranos N, Kontogeorgos G, Frangia K, Kokka E: Effect of fixation on interphase cytogenetic analysis by direct fluorescence in situ hybridization on cell imprints. Biotechnol Histochem 1997;72:148-151.
12. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldeman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-821.
13. Kallioniemi O, Kallioniemi A, Piper J, Isola J, Waldman F, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number of changes in solid tumors. Genes Chromsomes Cancer 1994;10:231-243.
14. Tuong K, Guilly MN, Gerbault-Sereau M, Malfoy B, Viehl P, Bourgeois CA, Dutrillaux B:Quantitative FISH by image cytometry for the detection of chromosome 1 imbalances in breast cancer: A novel approach analyzing chromosome rearrangements within interphase nuclei. Lab Invest 1998;78:1607-1613.
15. Roberts I, Wienberg J, Nacheva E, Grace C, Griffin D, Coleman N: Novel method for the production of multiple colour chromosome paints for use in karyotyping by fluorescence in situ hybridisation. Genes Chromosomes Cancer 1999;25:241-250.
16. Tanke HJ, Wiegant J, van Gijlswijk RP, Bezrookove V, Pattenier H, Heetebrij RJ, Talman EG, Raap AK, Vrolijk J: New strategy for multi-colour fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur J Hum Genet 1999;7:2-11.
17. Tubbs R, Skacel M, Pettay J, Powell R, Myles J, Hicks D, Sreenan J, Roche P, Stoler MH, Hainfeld J: Interobserver interpretative reproducibility of GOLDFISH, a first-generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma. Am J Surg Pathol 2002;26:908-913.
18. Coullin P, Philippe C, Ravise N, Bernheim A: Simultaneous fluorescence in-situ hybridization an R-banding by primed in-situ labelling. Chromosome Res 1999;7:241-242.
19. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J: Chromogenic in situ hybridization - A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 2000;157:1467-1472.
20. Nosé V, Scheithauer BW, Lloyd VL, Kovacs K, Horvath E, DeGirolami U, Kroll TG, Fletcher JA: Her-2/neu genomic aberrations in pituitary carcinoma. Abstracts 8th Pituitary Pathology Meeting, Delphi-Athens, Greece 2001. Endocr Pathol 2001;12:231.
21. Rey JA, Bello MJ, de Campos JM, Kusak ME, Martinez-Castro P, Benitez J: A case of pituitary adenoma with 58 chromosomes. Cancer Gen Cytogenet 1986;23:171-174.
22. Carpa E, Rindi G, Santi G, Spina MP, Scappaticci S: Chromosome abnormalities in a case of pituitary adenoma. Cancer Genet Cytogenet 1993;58:140-142.
23. Dietrich CU, Pandis N, Bjerre P, Scroder HD, Heim S: Simple numerical chromosomal aberrations in two pituitary adenomas. Cancer Gen Cytogenet 1993;69:118-121.
24. Rock JP, Babu VR, Drumheller T, Chason J: Cytogenetic findings in pituitary adenomas: Results of a pilot study. Surg Neurol 1993;40:224-229.
25. Finelli P, Giardino D, Rizzi N, Buiatiotis S, Virduci T, Franzin A, Losa M, Larizza L: Non-random trisomies of chromosomes 5, 8 and 12 in the prolactinoma subtype of pituitary adenomas: Conventional cytogenetics and interphase FISH study. Int J Cancer 2000;86:344-350.
26. Bettio D, Rizzi N, Giardino D, Persani L, Pecori-Giraldi F, Losa M, Larizza L: Cytogenetic study in pituitary adenomas. Cancer Genet Cytogenet 1997;98:131-136.
27. Finelli P, Pierantoni GM, Giardino D, Losa M, Rodeschini O, Fedele M, Valtorta E, Mortini P, Croce CM, Larizza L, Fusco A: The high mobility group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 2002;62:2398-23405.
28. Chandrasekharappa SC, Guru SC, Manickan P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ: Positional cloning of the gene for the multiple endocrine neoplasia type 1. Science 1997;276:404-407.
29. Kontogeorgos G, Kapranos N: Interphase analysis of chromosome 11 in human pituitary somatotroph adenomas by direct fluorescence in situ hybridization. Endocr Pathol 1996;7:203-206.
30. Stefaneanu L, Murray D, Kovacs K, Smyth HS: Comparative study of DNA content and interphase nucleolar organizer regions in human pituitary adenomas. Endocr Pathol 1990;1:182-187.
31. Kontogeorgos G, Kapranos N, Rologis D, Vamvassakis E, Papadopoulos N: DNA ploidy of pituitary adenomas assessed by image analysis. Anal Quant Cytol Histol 1996;18:144-150.
32. Lengauer C, Kinzler KW, Vogelstein B: Genetic instability in colorectal cancer. Nature 1997;386:623-627.
33. Harada K, Nishizaki T, Ozaki S, Kubota H, Harada K, Okamura T, Ito H, Sasaki K: Cytogenetic alterations in pituitary adenomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 1999;112:38-41.
34. Larson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-87.
35. DeLellis RA: Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic and molecular features. Lab Invest 1995;72:494-505.
36. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Olfield EH, Park WS, Pack S, Huang S, Agarwal SK, Siradanahalli CG, Guru SC, Manickan P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA: Mutations of the MEN-1 tumor suppressor gene in pituitary adenomas. Cancer Res 1997;57:5446-5451.
37. Stratakis CA, Schussheim DH, Freedman SM, Keill MF, Pack SD, Agarwal SK, Skarulis MC, Weil RJ, Lubensky IA, Zhuang Z, Oldfield EH, Marx SJ: Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2000;85:4776-4780.
38. Kontogeorgos G, Kapranos N, Tzavara I, Thalassinos N, Rologis D: Monosomy of chromosome 11 in pituitary adenoma in a patient associated with familial multiple endocrine neoplasia type 1. Clin Endocrinol 2001;54:117-120.
39. Tanaka C, Kimura T, Yang P, Moritani M, Yamaoka T, Yamada S, Sano T, Yoshimoto K, Itakura M:Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN-1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab 1998;83:2617-2620.
40. Metzger AK, Mohapatra G, Minn YA, Bollen AW, Lamborn K, Waldman FM, Wilson CB, Feuerstein BG: Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization. J Neurosurg 1999;90:306-314.
41. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA: Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas (Carney complex). J Clin Endocrinol Metab 2000;85:3860-3865.
42. Trautmann K, Thakker RV, Ellison DW, Ibrahim A, Lees PD, Harding B, Fischer C, Popp S, Bartram CR, Jauch A: Chromosomal aberrations in sporadic pituitary tumors. Int J Cancer 2001;91:809-814.
43. Tanaka C, Yoshimoto K, Yang P, Kimura T, Yamada S, Moritani M, Sano T, Itakura M: Infrequent mutations of p27Kip1 gene and trisomy 12 in a subset of human pituitary adenomas. J Clin Endocrinol Metab 1997;82:3141-3147.
44. Daniel M, Aviram A, Adams EF, Buchfelfer M, Berkai G, Fahlbousch R, Goldman B, Friedman E:Comparative genomic hybridization analysis of nonfunctioning pituitary tumors. J Clin Endocrinol Metab 1998;83:1801-1805.
45. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D: Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995;55:1613-1616.
46. Hui AB, Pang JC, Ko CW, Ng HK: Detection of chromosomal imbalances in growth hormonesecreting pituitary tumors by comparative genomic hybridization. Hum Pathol 1999;30:1019-1023.
47. Rickert CH, Dockhorn-Dworniczak B, Busch G, Moskopp D, Albert FK, Rama B, Paulus W: Increased chromosomal imbalances in recurrent pituitary adenomas. Acta Neuropathol 2001;102:615-620.